BioCentury
ARTICLE | Clinical News

NTx-265: Phase IIb data

May 31, 2010 7:00 AM UTC

Top-line data from the double-blind, international Phase IIb REGENESIS trial in 96 patients showed that NTx-265 missed the primary endpoint of a significantly greater absolute change in NIHSS score fr...